Arunesh Verma is President of Fresenius Kabi in the United States and a member of the company’s global Executive Leadership Team. Fresenius Kabi is a leading U.S. developer and manufacturer of injectable medicines and biosimilars.

Arun has deep experience in essential medicines with past roles of increasing responsibility at Cipla where he was CEO of North America, as well as Torrent Pharma, Sandoz, Dr. Reddy’s, and Novartis, where he began his career in sales.

Arun holds an MBA from Symbiosis Institute of Business Management, and a bachelor’s degree in pharmaceutical sciences, pharmacology and pharmaceutics from the University of Mumbai.